<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28970" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Shock</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Haseer Koya</surname>
            <given-names>Hayas</given-names>
          </name>
          <aff>Huggins Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Paul</surname>
            <given-names>Manju</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hayas Haseer Koya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manju Paul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28970.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Shock is a life-threatening manifestation of circulatory failure. Circulatory shock leads to cellular and tissue hypoxia resulting in cellular death and dysfunction of vital organs. Effects of shock are reversible in the early stages and a delay in diagnosis and/or timely initiation of treatment can lead to irreversible changes including multiorgan failure (MOF) and death. This activity reviews the evaluation and management of shock, and explains the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology and epidemiology of shock and describe the types of shock.</p></list-item><list-item><p>Outline the evaluation of a patient potentially in shock.</p></list-item><list-item><p>Summarize the treatment and management options available for shock.</p></list-item><list-item><p>Review the importance of improving care coordination among the interprofessional team to improve outcomes for patients in shock.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28970&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28970">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28970.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Shock is a life-threatening manifestation of circulatory failure.&#x000a0; Circulatory shock leads to cellular and tissue hypoxia resulting in cellular death and dysfunction of vital organs. Effects of shock are reversible in the early stages, and a delay in diagnosis and/or timely initiation of treatment can lead to irreversible changes, including multiorgan failure (MOF) and death.</p>
      </sec>
      <sec id="article-28970.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Shock is characterized by decreased oxygen delivery and/or increased oxygen consumption or inadequate oxygen utilization leading to cellular and tissue hypoxia. It is a life-threatening condition of circulatory failure and most commonly manifested as hypotension (systolic blood pressure less than 90 mm Hg or MAP less than 65 mmHg). Shock is the final manifestation of a complex list of etiologies and could be fatal without timely management. There are mainly four broad categories of shock: distributive, hypovolemic, cardiogenic, and obstructive.<xref ref-type="bibr" rid="article-28970.r1">[1]</xref>&#x000a0;The wide range of etiologies can contribute to each of these categories and are manifested by the final&#x000a0;outcome of shock. Undifferentiated shock means that the diagnosis of shock has been made; however, the underlying etiology has not been uncovered.</p>
        <p>
<bold>1. Distributive Shock</bold>
</p>
        <p>Characterized by peripheral vasodilatation.&#x000a0;</p>
        <p>Types of distributive shock include:</p>
        <p>
<bold>Septic Shock</bold>
</p>
        <p>Sepsis is defined as life-threatening organ dysfunction resulting from dysregulated host response to infection.<xref ref-type="bibr" rid="article-28970.r2">[2]</xref> Septic shock is a subset of sepsis with severe circulatory, cellular, and metabolic abnormalities resulting in tissue hypoperfusion manifested as hypotension which requires vasopressor therapy and elevated lactate levels (more than 2 mmol/L)</p>
        <p>The most common pathogens associated with sepsis and septic shock in the United States&#x000a0;are gram-positive bacteria, including streptococcal pneumonia and Enterococcus.</p>
        <p>
<bold>Systemic Inflammatory Response Syndrome</bold>
</p>
        <p>Systemic inflammatory response syndrome (SIRS) is a clinical syndrome of the vigorous inflammatory response caused by either infectious or noninfectious causes. Infectious causes include&#x000a0;pathogens such as gram-positive (most common) and gram-negative bacteria, fungi, viral infections (e.g., respiratory viruses), parasitic (e.g., malaria), rickettsial infections. Noninfectious causes of SIRS include but are not limited to pancreatitis, burns, fat embolism, air embolism, and amniotic fluid embolism</p>
        <p>
<bold>Anaphylactic Shock</bold>
</p>
        <p>Anaphylactic shock is a clinical syndrome of severe hypersensitivity reaction mediated by immunoglobulin E (Ig-E), resulting in cardiovascular collapse and respiratory distress due to bronchospasm. The immediate hypersensitivity reactions can occur within seconds to minutes after the presentation of the inciting antigen. Common allergens include drugs (e.g., antibiotics, NSAIDs), food, insect stings, and latex.</p>
        <p>
<bold>Neurogenic Shock</bold>
</p>
        <p>Neurogenic shock can occur in the setting of trauma to the spinal cord or the brain. The underlying mechanism is the disruption of the autonomic pathway resulting in decreased vascular resistance and changes in vagal tone.</p>
        <p>
<bold>Endocrine Shock</bold>
</p>
        <p>Due to underlying endocrine etiologies such as adrenal failure (Addisonian crisis) and myxedema.</p>
        <p>
<bold>2. Hypovolemic Shock</bold>
</p>
        <p>Hypovolemic shock is characterized by decreased intravascular volume and increased systemic venous assistance (compensatory the mechanism to maintain perfusion in the early stages of shock). In the later stages of shock due to progressive volume depletion, cardiac output also decreases and manifest as hypotension.&#x000a0;Hypovolemic shock divides into two broad subtypes: hemorrhagic and non-hemorrhagic.</p>
        <p>Common causes of hemorrhagic hypovolemic shock include</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastrointestinal bleed (both upper and lower gastrointestinal bleed (e.g., variceal bleed, portal hypertensive gastropathy bleed, peptic ulcer, diverticulosis) trauma</p>
          </list-item>
          <list-item>
            <p>Vascular etiologies (e.g., aortoenteric fistula, ruptured abdominal aortic aneurysm, tumor eroding into a major blood vessel)</p>
          </list-item>
          <list-item>
            <p>Spontaneous bleeding in the setting of anticoagulant use (in the setting of supratherapeutic INR from drug interactions)</p>
          </list-item>
        </list>
        <p>Common causes of non-hemorrhagic hypovolemic shock include:</p>
        <list list-type="bullet">
          <list-item>
            <p>GI losses - the setting of vomiting, diarrhea, NG suction, or drains.</p>
          </list-item>
          <list-item>
            <p>Renal losses - medication-induced diuresis, endocrine disorders such as hypoaldosteronism.</p>
          </list-item>
          <list-item>
            <p>Skin losses/insensible losses - burns, Stevens-Johnson syndrome, Toxic epidermal necrolysis, heatstroke, pyrexia.</p>
          </list-item>
          <list-item>
            <p>Third-space loss - in the setting of pancreatitis, cirrhosis, intestinal obstruction, trauma.</p>
          </list-item>
        </list>
        <p>
<bold>3. Cardiogenic Shock</bold>
</p>
        <p>Due to intracardiac causes leading to decreased cardiac output and systemic hypoperfusion. Different subtypes of etiologies contributing to cardiogenic shock include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiomyopathies - include acute myocardial infarction affecting more than 40% of the left ventricle, acute myocardial infarction in the setting of multi-vessel coronary artery disease, right ventricular myocardial infarction, fulminant dilated cardiomyopathy, cardiac arrest (due to myocardial stunning), myocarditis.</p>
          </list-item>
          <list-item>
            <p>Arrhythmias - both tachy- and bradyarrhythmias</p>
          </list-item>
          <list-item>
            <p>Mechanical - severe aortic insufficiency, severe mitral insufficiency, rupture of papillary muscles, or chordae tendinae trauma rupture of ventricular free wall aneurysm.</p>
          </list-item>
        </list>
        <p>
<bold>4. Obstructive Shock</bold>
</p>
        <p>Mostly due to extracardiac causes leading to a decrease in the left ventricular cardiac output</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary vascular - due to impaired blood flow from the right heart to the left heart. Examples include hemodynamically significant pulmonary embolism, severe pulmonary hypertension.<xref ref-type="bibr" rid="article-28970.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Mechanical - impaired filling of right heart or due to decreased venous return to the right heart due to extrinsic compression. Examples include tension pneumothorax, pericardial tamponade, restrictive cardiomyopathy, constrictive pericarditis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28970.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Distributive shock is the most common type of shock, followed by hypovolemic and cardiogenic shock. Obstructive shock is relatively less common. The most common type of distributive shock is septic shock and has a mortality rate between 40 to 50%.</p>
      </sec>
      <sec id="article-28970.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hypoxia at the cellular level causes a series of physiologic and biochemical changes, resulting in acidosis and a decrease in regional blood flow, which further worsens the tissue hypoxia.<xref ref-type="bibr" rid="article-28970.r4">[4]</xref>&#x000a0;In hypovolemic, obstructive, and cardiogenic shock, there is a decrease in cardiac output and decreased oxygen transport. In distributive shock, there is decreased peripheral vascular resistance and abnormal oxygen extraction. Excitement is a spectrum of physiologic changes, ranging from early stages, which are&#x000a0;reversible to the final stages, which are&#x000a0;irreversible with multiorgan failure and death. Generally,&#x000a0;shock has the following three stages:</p>
        <list list-type="order">
          <list-item>
            <p>Pre-shock or compensated shock - As the name suggests, this stage&#x000a0;is characterized by compensatory mechanisms to counter the decrease in tissue perfusion, including tachycardia, peripheral vasoconstriction, and changes in systemic blood pressure</p>
          </list-item>
          <list-item>
            <p>Shock&#x000a0;- During this stage, most of the classic signs and symptoms of shock appear due to early organ dysfunction, resulting from the progression of&#x000a0;the pre-shock stage as the compensatory mechanisms become insufficient.</p>
          </list-item>
          <list-item>
            <p>End-organ dysfunction&#x000a0;-&#x000a0;This is the final stage, leading to irreversible organ dysfunction, multiorgan failure,&#x000a0;and death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28970.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A focused history should be obtained from the patient (if feasible) and/or patient's relatives. Also, a review of the patient&#x02019;s outpatient medical records (information regarding risk factors, medications, and trend of baseline vital signs including blood pressure), as well as hospital medical records, could give valuable clues regarding the patient's risk for shock and potential etiology. Clinical features and symptoms can vary according to the type and stage of shock. The most common clinical features/labs which are&#x000a0;suggestive of shock include hypotension, tachycardia, tachypnea, obtundation or abnormal mental status, cold, clammy extremities, mottled skin, oliguria, metabolic acidosis, and hyperlactatemia.<xref ref-type="bibr" rid="article-28970.r5">[5]</xref><xref ref-type="bibr" rid="article-28970.r6">[6]</xref> Also, features pertaining to the underlying cause of the shock can be present.</p>
        <p>Patients with hypovolemic shock can have general features as mentioned above as well as evidence of orthostatic hypotension, pallor, flattened jugular venous pulsations, may have sequelae of chronic liver disease (in case of variceal bleeding).</p>
        <p>Patients with septic shock may present with symptoms suggestive of the source of infection (example-skin manifestations of primary infection such as erysipelas, cellulitis, necrotizing soft-tissue infections), and cutaneous manifestations of infective endocarditis.</p>
        <p>Patients with anaphylactic shock can have hypotension, flushing, urticaria, tachypnea, hoarseness of voice, oral and facial edema, hives, wheeze, inspiratory stridor, and history of exposure to common allergens such as medications or food items the patient is allergic to or insect stings.</p>
        <p>Tension pneumothorax should be suspected in a patient with undifferentiated shock who has tachypnea, unilateral pleuritic chest pain, absent or diminished breath sounds, tracheal deviation to the normal side, distended neck veins and also has pertinent risk factors for tension pneumothorax such as recent trauma, mechanical ventilation, underlying cystic lung disease).</p>
        <p>In a patient with undifferentiated shock, diagnostic clues to pericardial tamponade as the etiology include dyspnea, the Beck triad (elevated jugular venous pressure, muffled heart sounds, hypotension), pulses paradoxus, and known risk factors such as trauma, the recent history of pericardial effusion, and thoracic procedures.&#x000a0;</p>
        <p>Cardiogenic&#x000a0;shock should be considered as the etiology if the&#x000a0;patient with undifferentiated shock had chest pain suggestive of cardiac origin, narrow pulse pressure, elevated jugular venous pulsations or lung crackles, and significant arrhythmias on telemetry or EKG.</p>
      </sec>
      <sec id="article-28970.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Resuscitation should not delay while investigating the etiology of undifferentiated shock. Physicians should have a high clinical suspicion for the presence of&#x000a0;shock, and an attempt to stratify the severity of the shock should also take place to assess the need for emergent or early interventions. Evaluation of undifferentiated shock should begin with a thorough history and physical examination.</p>
        <p>Besides&#x000a0;telemetry monitoring, a 12-lead electrocardiogram should be obtained. ECGs might show evidence of acute coronary syndrome, arrhythmias, or provide diagnostic clues suggestive of pericardial effusion or pulmonary embolism.</p>
        <p>Laboratory tests in a patient with undifferentiated shock should include a CBC and differential, renal and liver function tests, serum lactate level, cardiac biomarkers, D-dimer level, coagulation profile, type and screen for a possible&#x000a0;blood transfusion if appropriate (if concern for hemorrhagic shock), blood and urine cultures, and blood gas analysis. Initial imaging studies recommended in patients with undifferentiated shock and hypotension include chest x-rays to look for the source of infection such as pneumonia, complications of shock such as ARDS, clinical findings supporting the diagnosis of pulmonary edema in cardiogenic shock, widened mediastinum in aortic dissection. CT scans can also assist in unmasking the etiology of shock in appropriate clinical scenarios. Point of care ultrasonography or focused cardiac ultrasound&#x000a0;is also a useful bedside diagnostic tool.<xref ref-type="bibr" rid="article-28970.r7">[7]</xref></p>
      </sec>
      <sec id="article-28970.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The initial approach to management is the stabilization of the airway and breathing with oxygen and oral mechanical ventilation when needed.&#x000a0;Peripheral IV or intraosseous&#x000a0;infusion (IO)&#x000a0;access should be&#x000a0;obtained.&#x000a0;Central venous access may be required in the setting of shock if there is difficulty securing peripheral venous access, or the patient needs prolonged vasopressor therapy or large-volume resuscitation. Immediate treatment with intravenous (IV) fluid should be initiated, followed by vasopressor therapy, if needed, to maintain tissue perfusion. Depending on the underlying etiology of shock, specific therapies might also be needed.</p>
        <p>Septic shock - initial aggressive fluid resuscitation with IV isotonic crystalloids 30 mL/kg within 3 hrs with additional fluid based on frequent reassessment, empiric antibiotic therapy within one hr.&#x000a0;<xref ref-type="bibr" rid="article-28970.r8">[8]</xref> For patients with septic shock requiring vasopressors, target a mean arterial pressure (MAP) of 65 mmHg. The first choice of a vasopressor is norepinephrine,&#x000a0;with the addition of vasopressin if refractory.<xref ref-type="bibr" rid="article-28970.r9">[9]</xref></p>
        <p>Anaphylactic shock - aggressive IV fluid resuscitation with 4&#x000a0;to 6 L of IV crystalloids. Stop the offending agent, intramuscular epinephrine, antihistamines, corticosteroids, nebulized albuterol.</p>
        <p>In adrenal crisis - judicious fluid resuscitation, IV dexamethasone.</p>
        <p>Hypovolemic shock - obtain two large-bore IVs or central line. Place the patient in the Trendelenburg position. Aggressive IV fluid resuscitation with 2&#x000a0;to 4 L of isotonic crystalloids. PRBC transfusion if ongoing bleed.&#x000a0;Appropriate medical or interventional strategies to treat the underlying etiology. Continue with isotonic crystalloids and use vasopressors if needed</p>
        <p>Obstructive shock&#x000a0;- the judicious use of IV crystalloids. If shock persists, early initiation of vasopressors-norepinephrine is the first choice and add vasopressin if refractory. Continue IV fluids but monitor very&#x000a0;closely.&#x000a0;</p>
        <p>If acute massive pulmonary embolism -thrombolysis. Judicious use of IV fluids has a paradoxical worsening of hypotension; it may develop due to severe right ventricular dilatation and septal bowing compromising&#x000a0;left ventricle filling.&#x000a0;</p>
        <p>If tension pneumothorax&#x000a0;- needle thoracotomy followed by tube thoracotomy. If cardiac tamponade-pericardiocentesis, significant clinical improvement is possible, even with minimal fluid removal).</p>
        <p>Cardiogenic shock - if unstable tachyarrhythmia or bradyarrhythmias, initiate ACLS protocol and cardioversion. Judicious use of IV fluids in the absence of pulmonary edema. Consider inotropes (dobutamine is the most commonly used agent) or intra-aortic balloon pump (IABP), if refractory shock, and vasopressor (norepinephrine) with inotropes.</p>
        <p>If STEMI&#x000a0;- consider thrombolysis or coronary revascularization procedures and or IABP.</p>
      </sec>
      <sec id="article-28970.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Uncovering the etiology of undifferentiated shock is very important. In a patient presenting with undifferentiated shock, the differential diagnosis includes a wide variety of etiologies that falls under the four major categories of shock, as outlined above. Also, sometimes patients can have a combination of shock syndromes. Another differential is "pharmacological shock," which results from vasodilatation or myocardial depression from medications (e.g., benzodiazepines, beta-blockers, calcium channel blockers, opiates, anticholinergics, and sildenafil).</p>
      </sec>
      <sec id="article-28970.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Sepsis and septic shock, in general,&#x000a0;are associated with long-term morbidity and mortality, with many of the survivors requiring placement into long-term acute care facilities or post-acute&#x000a0;care centers.<xref ref-type="bibr" rid="article-28970.r10">[10]</xref><xref ref-type="bibr" rid="article-28970.r11">[11]</xref>&#x000a0;Septic shock has a mortality rate between 40% and 50%. Cardiogenic shock has a mortality rate ranging from 50% to 75%,&#x000a0;an improvement over&#x000a0;prior mortality rates. Hypovolemic and obstructive shock generally&#x000a0;have much lower mortality and respond better to timely treatment.&#x000a0;</p>
      </sec>
      <sec id="article-28970.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Shock is a clinical manifestation of circulatory failure and is associated with high morbidity and mortality.</p>
          </list-item>
          <list-item>
            <p>There are broadly four types of shock: distributive, cardiogenic, hypovolemic, and obstructive.</p>
          </list-item>
          <list-item>
            <p>An accurate diagnosis requires a good understanding of underlying pathophysiology, clinical, biochemical, and hemodynamic manifestations of the different types of&#x000a0;shock.</p>
          </list-item>
          <list-item>
            <p>Serum lactate level is a useful risk stratification tool in managing undifferentiated shock.</p>
          </list-item>
          <list-item>
            <p>Timely diagnosis and initiation of appropriate&#x000a0;therapy are of paramount importance as it can prevent progression to the reversible shock, multiorgan failure, and death.</p>
          </list-item>
          <list-item>
            <p>Treatment includes hemodynamic stabilization and correction of underlying etiology of shock.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28970.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of patients with shock calls for a collaborative, interprofessional approach. Clinicians must react promptly to the emergency and determine the precise cause of shock. Nursing will be on hand to assist at every step of the way, assisting with measures such as intubation and administering medications. Pharmacists must rapidly prepare and deliver the needed drugs and yet still verify that dosing and interactions do not present a problem. Depending on the etiology, various specialists may also be called in on the case. Each area will need to act and react as the situation dictates. WIth interprofessional cooperation, these patients will stand a better chance of recovery from shock with minimal deleterious effects. [Level 5]</p>
      </sec>
      <sec id="article-28970.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28970&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28970">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/shock/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28970">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28970/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28970">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28970.s14">
        <title>References</title>
        <ref id="article-28970.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Circulatory shock.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Feb</month>
            <day>06</day>
            <volume>370</volume>
            <issue>6</issue>
            <fpage>583</fpage>
            <pub-id pub-id-type="pmid">24499231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>van der Poll</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Severe sepsis and septic shock.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Aug</month>
            <day>29</day>
            <volume>369</volume>
            <issue>9</issue>
            <fpage>840</fpage>
            <page-range>840-51</page-range>
            <pub-id pub-id-type="pmid">23984731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smulders</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction.</article-title>
            <source>Cardiovasc Res</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-33</page-range>
            <pub-id pub-id-type="pmid">11033105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barber</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Shires</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Cell damage after shock.</article-title>
            <source>New Horiz</source>
            <year>1996</year>
            <month>May</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-7</page-range>
            <pub-id pub-id-type="pmid">8774792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>VX</given-names>
              </name>
              <name>
                <surname>Iwashyna</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Brunkhorst</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Rea</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Scherag</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubenfeld</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shankar-Hari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deutschman</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Escobar</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Feb</month>
            <day>23</day>
            <volume>315</volume>
            <issue>8</issue>
            <fpage>762</fpage>
            <page-range>762-74</page-range>
            <pub-id pub-id-type="pmid">26903335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kraut</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Madias</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Lactic acidosis.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>12</day>
            <volume>372</volume>
            <issue>11</issue>
            <fpage>1078</fpage>
            <page-range>1078-9</page-range>
            <pub-id pub-id-type="pmid">25760366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shokoohi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boniface</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Pourmand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Davison</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Buhumaid</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Salimian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Bedside Ultrasound Reduces Diagnostic Uncertainty and Guides Resuscitation in Patients With Undifferentiated Hypotension.</article-title>
            <source>Crit Care Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>2562</fpage>
            <page-range>2562-9</page-range>
            <pub-id pub-id-type="pmid">26575653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howell</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Management of Sepsis and Septic Shock.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Feb</month>
            <day>28</day>
            <volume>317</volume>
            <issue>8</issue>
            <fpage>847</fpage>
            <page-range>847-848</page-range>
            <pub-id pub-id-type="pmid">28114603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hylands</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Asfar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frenette</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Beaudoin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Belley-C&#x000f4;t&#x000e9;</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>D'Aragon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Laake</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Siemieniuk</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Charbonney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lauzier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kwong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vandvik</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lamontagne</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension.</article-title>
            <source>Can J Anaesth</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>703</fpage>
            <page-range>703-715</page-range>
            <pub-id pub-id-type="pmid">28497426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shankar-Hari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>VX</given-names>
              </name>
              <name>
                <surname>Deutschman</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Rubenfeld</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <collab>Sepsis Definitions Task Force</collab>
            </person-group>
            <article-title>Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Feb</month>
            <day>23</day>
            <volume>315</volume>
            <issue>8</issue>
            <fpage>775</fpage>
            <page-range>775-87</page-range>
            <pub-id pub-id-type="pmid">26903336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28970.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cecconi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sepsis and septic shock.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Jul</month>
            <day>07</day>
            <volume>392</volume>
            <issue>10141</issue>
            <fpage>75</fpage>
            <page-range>75-87</page-range>
            <pub-id pub-id-type="pmid">29937192</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
